Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Three resistance mutations identified in Prof. Yardena Samuels’s lab may become targets for powerful new immunotherapies
Researchers reveal early response of tumor vessels to anti-cancer therapy
The treatment, approved for use in 31 countries, is now being marketed in Germany, Italy, Israel and Mexico